CONMED Corporation (CNMD)
48.51
-2.47 (-4.85%)
At close: Apr 15, 2025, 3:59 PM
47.09
-2.93%
After-hours: Apr 15, 2025, 07:56 PM EDT
-4.85% (1D)
| Bid | 47.07 |
| Market Cap | 1.5B |
| Revenue (ttm) | 1.31B |
| Net Income (ttm) | 132.42M |
| EPS (ttm) | 4.25 |
| PE Ratio (ttm) | 11.41 |
| Forward PE | 9.94 |
| Analyst | Buy |
| Ask | 50.07 |
| Volume | 353,629 |
| Avg. Volume (20D) | 622,643.4 |
| Open | 50.85 |
| Previous Close | 50.98 |
| Day's Range | 47.89 - 51.08 |
| 52-Week Range | 47.89 - 78.58 |
| Beta | 1.29 |
About CNMD
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as suppor...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 23, 1987
Employees 3,900
Stock Exchange NYSE
Ticker Symbol CNMD
Website https://www.conmed.com
Analyst Forecast
According to 5 analyst ratings, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is $75, which is an increase of 54.61% from the latest price.
Stock ForecastsNext Earnings Release
CONMED Corporation is scheduled to release its earnings on Apr 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-8.97%
Conmed shares are trading lower after the company ...
Unlock content with
Pro Subscription
2 months ago
+1.54%
Conmed shares are trading lower after the company issued FY25 earnings and revenue guidance below estimates.
